Cargando…

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience

Whole-brain radiotherapy (WBRT) has been an important component of treatment for primary central nervous system lymphoma (PCNSL), but delayed neurotoxicity has been a matter of concern. We have employed partial-brain radiotherapy (PBRT) with wide margins for PCNSL patients with a single lesion or a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwabuchi, Michio, Shibamoto, Yuta, Sugie, Chikao, Ayakawa, Shiho, Ogino, Hiroyuki, Baba, Fumiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Clinical Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795951/ https://www.ncbi.nlm.nih.gov/pubmed/26661856 http://dx.doi.org/10.1093/jrr/rrv085

Ejemplares similares

Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results
por: Baba, Fumiya, et al.
Publicado: (2009)

Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2012)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Comparison of multileaf collimator and conventional circular collimator systems in Cyberknife stereotactic radiotherapy
por: Murai, Taro, et al.
Publicado: (2017)

Immune-maximizing (IMAX) therapy for cancer: Combination of dendritic cell vaccine and intensity-modulated radiation
por: SHIBAMOTO, YUTA, et al.
Publicado: (2013)

Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
por: Baba, Fumiya, et al.
Publicado: (2010)

Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer
por: Manabe, Yoshihiko, et al.
Publicado: (2014)

Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study
por: Miyakawa, Akifumi, et al.
Publicado: (2017)

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study
por: Hashimoto, Shingo, et al.
Publicado: (2016)

Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution
por: Iwata, Hiromitsu, et al.
Publicado: (2020)

Radiation Therapy for Primary Central Nervous System Lymphoma
por: Shibamoto, Yuta
Publicado: (2013)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Local Control of Primary Dural Central Nervous System Lymphoma Achieved With Radiotherapy
por: Vallejo, Alexandra, et al.
Publicado: (2021)

Dose–volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays
por: Hayashi, Akihiro, et al.
Publicado: (2015)

Radiotherapy for a rare phosphaturic mesenchymal tumor in the middle ear presenting with oncogenic osteomalacia: A case report
por: Takaoka, Taiki, et al.
Publicado: (2021)

Impact of advanced radiotherapy techniques and dose intensification on toxicity of salvage radiotherapy after radical prostatectomy
por: Tomita, Natsuo, et al.
Publicado: (2020)

Intensity‐modulated radiation therapy for multiple targets with tomotherapy using multiple sets of static ports from different angles
por: Manabe, Yoshihiko, et al.
Publicado: (2020)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2016)

CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas
por: MANABE, Yoshihiko, et al.
Publicado: (2017)

Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma
por: Wu, Susan Y, et al.
Publicado: (2023)

Stereotactic Radiotherapy for Intramedullary Spinal Arteriovenous Malformations
por: Mori, Yoshimasa, et al.
Publicado: (2018)

Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancer
por: Takemoto, Shinya, et al.
Publicado: (2019)

Changes in pulmonary function and their correlation with dose–volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer
por: Takemoto, Shinya, et al.
Publicado: (2021)

Primary Central Nervous System Lymphoma  with Peripheral Nerve Involvement:  Case Report
por: Mori, Yoshimasa, et al.
Publicado: (2019)

Efficacy of stereotactic radiotherapy for brain metastases using dynamic jaws technology in the helical tomotherapy system
por: Murai, Taro, et al.
Publicado: (2016)

RONC-03. Secondary Neoplasms in Children with Central Nervous System (CNS) Tumors Following Radiotherapy in the Modern Era
por: Indelicato, Daniel, et al.
Publicado: (2022)

Helical and Static-port Tomotherapy Using the Newly-developed Dynamic Jaws Technology for Lung Cancer
por: Manabe, Yoshihiko, et al.
Publicado: (2015)

Central Nervous System Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review
por: Albakr, Abdulrahman, et al.
Publicado: (2018)

Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly‐developed tumor‐tracking system and cyberknife
por: Manabe, Yoshihiko, et al.
Publicado: (2021)

Comparison of intensity-modulated radiotherapy with the 5-field technique, helical tomotherapy and volumetric modulated arc therapy for localized prostate cancer
por: Kita, Nozomi, et al.
Publicado: (2022)

Biological Effects of Continuous Low-Dose-Rate Irradiation in Silkworms and Mice: Growth Promotion and Tumor Transplantability
por: Nakashima, Masahiro, et al.
Publicado: (2018)

Changes in the Proliferation Rate, Clonogenicity, and Radiosensitivity of Cultured Cells During and After Continuous Low-Dose-Rate Irradiation
por: Wang, Zhen, et al.
Publicado: (2019)

Helical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases
por: Yamada, Yuki, et al.
Publicado: (2022)

Biological effects of prostaglandin E2-EP4 antagonist (AAT-008) in murine colon cancer in vivo: enhancement of immune response to radiotherapy and potential as a radiosensitizer
por: Manabe, Yoshihiko, et al.
Publicado: (2023)

Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience
por: Glicksman, Rachel M, et al.
Publicado: (2020)

Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode
por: Murai, Taro, et al.
Publicado: (2013)

Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease
por: Ishikura, Satoshi, et al.
Publicado: (2020)

Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort
por: Cobert, Julien, et al.
Publicado: (2009)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1d2uh4iaqvknddeo6ejp803oqv